Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity
Pre-publication versions of this article are available by contacting email@example.com.
|25 Feb 2016||Submitted||Original manuscript|
|27 Apr 2016||Reviewed||Reviewer Report - Lingegowda Selanere Mangala|
|15 Jul 2016||Reviewed||Reviewer Report - Yong-Hua Yang|
|26 Jul 2016||Reviewed||Reviewer Report - Giuseppe Giannini|
|20 Oct 2016||Author responded||Author comments - Salundi Basappa|
|Resubmission - Version 2|
|20 Oct 2016||Submitted||Manuscript version 2|
|6 Feb 2017||Author responded||Author comments - Salundi Basappa|
|Resubmission - Version 3|
|6 Feb 2017||Submitted||Manuscript version 3|
|8 Mar 2017||Author responded||Author comments - CP Baburajeev|
|Resubmission - Version 4|
|8 Mar 2017||Submitted||Manuscript version 4|
|14 Mar 2017||Author responded||Author comments - CP Baburajeev|
|Resubmission - Version 5|
|14 Mar 2017||Submitted||Manuscript version 5|
|22 Mar 2017||Editorially accepted|
|31 Mar 2017||Article published||10.1186/s12885-017-3214-8|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.